Group 1 - The core viewpoint of the news is that Chengyitong experienced a decline in stock price, with a drop of 5.04% to 21.68 CNY per share, and a trading volume of 257 million CNY, resulting in a total market capitalization of 5.92 billion CNY [1] - Chengyitong, established on July 22, 2003, and listed on March 19, 2015, is based in Beijing and specializes in providing overall solutions for pharmaceutical and biomanufacturing automation control systems, as well as the research, production, and sales of rehabilitation medical devices [1] - The company's main business revenue composition is 71.11% from intelligent manufacturing and 28.89% from rehabilitation medical business [1] Group 2 - From the perspective of major fund holdings, Beixin Ruifeng Fund has one fund heavily invested in Chengyitong, specifically the Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056), which reduced its holdings by 40,000 shares in the second quarter, now holding 200,000 shares, accounting for 4.67% of the fund's net value [2] - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) was established on March 27, 2015, with a latest scale of 89.38 million CNY, and has achieved a year-to-date return of 38.34%, ranking 1631 out of 8184 in its category [2] - The fund manager, Pang Wenjie, has a tenure of 5 years and 95 days, with the fund's total asset scale at 170 million CNY, achieving a best return of 44.46% and a worst return of -44.1% during his tenure [2]
诚益通股价跌5.04%,北信瑞丰基金旗下1只基金重仓,持有20万股浮亏损失23万元